AU2001270851A1 - Peptides and their use in assays for cardiovascular disease - Google Patents

Peptides and their use in assays for cardiovascular disease

Info

Publication number
AU2001270851A1
AU2001270851A1 AU2001270851A AU7085101A AU2001270851A1 AU 2001270851 A1 AU2001270851 A1 AU 2001270851A1 AU 2001270851 A AU2001270851 A AU 2001270851A AU 7085101 A AU7085101 A AU 7085101A AU 2001270851 A1 AU2001270851 A1 AU 2001270851A1
Authority
AU
Australia
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270851A
Other languages
English (en)
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ark Therapeutics Ltd
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of AU2001270851A1 publication Critical patent/AU2001270851A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001270851A 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease Abandoned AU2001270851A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017641 2000-07-18
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use
PCT/GB2001/003212 WO2002006314A2 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Publications (1)

Publication Number Publication Date
AU2001270851A1 true AU2001270851A1 (en) 2002-01-30

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270851A Abandoned AU2001270851A1 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Country Status (12)

Country Link
US (2) US20040091934A1 (cg-RX-API-DMAC7.html)
EP (1) EP1301537B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004504327A (cg-RX-API-DMAC7.html)
AT (1) ATE408626T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001270851A1 (cg-RX-API-DMAC7.html)
CA (1) CA2417789A1 (cg-RX-API-DMAC7.html)
DE (1) DE60135846D1 (cg-RX-API-DMAC7.html)
DK (1) DK1301537T3 (cg-RX-API-DMAC7.html)
ES (1) ES2312455T3 (cg-RX-API-DMAC7.html)
GB (1) GB0017641D0 (cg-RX-API-DMAC7.html)
PT (1) PT1301537E (cg-RX-API-DMAC7.html)
WO (1) WO2002006314A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
NZ532217A (en) 2001-09-28 2006-12-22 Esperion Therapeutics Inc Use of an alpha helical apolipoprotein or HDL associating protein adapted to be administered locally to prevent or reduce stenosis or restenosis or to stabilize a plaque
EP1732383A4 (en) 2004-04-06 2007-05-02 Cedars Sinai Medical Center PREVENTION AND TREATMENT OF VASCULAR DISEASES WITH RECOMBINANT ADENO ASSOCIATED VIRUS VECTORS THAT CODE APOLIPOPROTEIN A-I AND APOLIPOPROTEIN A-I MILANO
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
MX2009006744A (es) * 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
WO2012074725A2 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
JP2013544243A (ja) 2010-11-12 2013-12-12 シーダース シナイ メディカル センター 動脈瘤の治療及び/又は予防のための免疫調節方法及びシステム
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
CA2294355C (en) * 1997-06-20 2006-11-28 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
ES2312455T3 (es) 2009-03-01
WO2002006314A3 (en) 2002-04-18
EP1301537A2 (en) 2003-04-16
US20080261234A1 (en) 2008-10-23
DK1301537T3 (da) 2008-12-08
GB0017641D0 (en) 2000-09-06
DE60135846D1 (de) 2008-10-30
US20040091934A1 (en) 2004-05-13
CA2417789A1 (en) 2002-01-24
JP2004504327A (ja) 2004-02-12
PT1301537E (pt) 2008-12-04
EP1301537B1 (en) 2008-09-17
ATE408626T1 (de) 2008-10-15
WO2002006314A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
PT1301537E (pt) Péptidos e sua utilização em ensaios para doença cardiovascular
Cunningham et al. Proline specific peptidases
DE69940429D1 (de) Peptidinhibitoren der ns3-protease des hepatoitis c virus
ATE500323T1 (de) Subtilisin-variante
WO2002006457A3 (en) Novel lipase genes
WO1998049286A3 (en) Directed evolution of enzymes and antibodies
WO2005013666A3 (en) Novel translocation assay
WO2002018635A8 (en) Use of nonviable particles comprising an internal control (ic) nucleic acid
NO881670D0 (no) Diagnostisk proeve paa inhibitor for plasminogenaktivatorer av vev- og urokinasetype, samt gen som koder for inhibitoren.
Tsushima et al. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
DE60027030D1 (de) Membrantranslokierendes peptid als wirkstofftransportsystem
EP1285070A4 (en) RECOMBINANT MICROORGANISMS THAT EXPRESS AN ENZYME OF POLYHYDROXYALKANOAT BIOSYNTHESIS AND INTRACELLULAR PHA-DEPOLYMERASE
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
ATE329015T1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase- ähnlicher aktivität.
Szpacenko et al. A different form of the Ca2+-dependent proteinase activated by micromolar levels of Ca2+
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO2001064912A3 (en) Triazine degrading enzymes
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
Slon-Usakiewicz et al. Design of P1 ‘and P3 ‘Residues of Trivalent Thrombin Inhibitors and Their Crystal Structures
WO2002102847A1 (fr) Nouveau ligand et son adn
AU4908799A (en) Determination of the hydrophobic pulmonary surfactant protein sp-c
WO2002036635A3 (en) Monoclonal antibodies for assaying lipid transfer proteins
NZ504633A (en) A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
WO2004046371A3 (en) Lipid phosphatase assays in disease and drug discovery
ATE510922T1 (de) Induzierbare promotoren